Rechercher des études
Résultats de recherche
This case series aims to evaluate the effectiveness and tolerability of Oral Sulfate Solution (OSS) in patients who had previously experienced poor colonoscopy preparation.
Conditions:
Colonoscopy | Bowel PreparationEmplacement:
- Hotel Dieu Hospital, Kingston, Ontario, Canada
Sexe:
ALLÂges:
Over 18The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grfating (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and cerebrovascular events in women undergoing coronary artery bypass grfating (CABG). The investigators will compare major adverse cardiac and cerebrovascular events (death, stroke, non-procedural myocardial infarction, repeat revascularization, and hospital readmission for acute coronary syndrome or heart failure) in a cohort of 2,000 women randomized 1:1 to MAG or SAG (690 from the parent ROMA trial + 1,310 from ROMA:Women). Differences by important clinical and surgical subgroups (patients younger or older than 70 years, diabetics, racial and ethnic minorities, on vs off pump CABG, type of arterial grafts used) will also be evaluated. The women enrolled in the ongoing ROMA trial (anticipated to be approximately 690) will be included in ROMA:Women, increasing efficiency and reducing enrollment time. Hypothesis 1.0. MAG will reduce the incidence of major adverse cardiac and cerebrovascular events. Hypothesis 1.1. The improvement with MAG will be consistent across key subgroups. Aim 2: Determine the impact of MAG vs SAG on generic and disease-specific QOL, physical and mental health symptoms in women undergoing CABG. The investigators will compare generic (SF-12, EQ-5D) and disease-specific (Seattle Angina Questionnaire) QOL and physical and mental health symptoms (PROMIS-29) in a sub-cohort of 500 women randomized 1:1 to MAG or SAG (including those enrolled in ROMA:QOL). Differences by important subgroups (as defined above) will also be evaluated. Hypothesis 2.0. MAG will improve generic and disease-specific QOL compared to SAG. Hypothesis 2.1. MAG will improve physical and mental health symptoms compared to SAG. Hypothesis 2.2. The improvement with MAG will be consistent across key subgroups.
Conditions:
Coronary Artery Disease | Heart Diseases | Coronary Artery Bypass GraftingEmplacement:
- Hamilton General Hospital, Hamilton, Ontario, Canada
- Sunnybrook Health Sciences, Toronto, Ontario, Canada
- Royal Victoria Hospital, Montréal, Quebec, Canada
- NL Health Services, St. John's, Newfoundland and Labrador, Canada
- Health Sciences North, Sudbury, Ontario, Canada
- University Hospital of Montreal, Montréal, Quebec, Canada
- St. Boniface General Hospital, Winnipeg, Manitoba, Canada
- London Health Sciences, London, Ontario, Canada
- Toronto General Hospital, Toronto, Ontario, Canada
- Institut Universitaire de Cardiologie et de Pneumologie de Québec, Ste Foy, Quebec, Canada
- Horizon Health Network - Saint John Regional Hospital, Saint John, New Brunswick, Canada
- University of Ottawa Heart Institute, Ottawa, Ontario, Canada
- Montreal Heart Institute, Montréal, Quebec, Canada
Sexe:
FEMALEÂges:
Over 18Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting
Conditions:
Nausea and Vomiting, PostoperativeEmplacement:
- The Hospital for Sick Children, Toronto, Ontario, Canada
- McGill University Health Centre - The Montréal Children's Hospital, Montréal, Quebec, Canada
Sexe:
ALLÂges:
Under 17This study aims to show that giving high dose, intravenous vitamin C in addition to standard care to burned critically ill patients will be associated with less organ dysfunction, improved survival and a quicker rate of recovery. In this study, all patients will receive standard care and of the patients will also receive high dose intravenous vitamin C, while the other half of patients will receive placebo.
Conditions:
Shock | Thermal BurnEmplacement:
- Sunnybrook Health Sciences Centre, Ross Tilley Burn Centre, Toronto, Ontario, Canada
- Hamilton General Hospital, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
- Centre de recherche du CHUM, Montréal, Quebec, Canada
- QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
Sexe:
ALLÂges:
Over 18Project EXCEL will provide community or online exercise programs to rural and remote and under-served cancer survivors, as well as encourage participants to become life-long exercisers. Exercise is an evidence-based self-management strategy that benefits all cancer survivors. However, most cancer survivors who live in remote or rural places don't have adequate opportunities to be involved in exercise programs that are tailored to their needs.
Conditions:
Cancer | Prostate Cancer | Head and Neck Cancer | Breast Cancer | Colon Cancer | Cancer CaregiversEmplacement:
- Health and Wellness Lab, University of Calgary, Calgary, Alberta, Canada
- University of Alberta, Edmonton, Alberta, Canada
- Dalhousie University, Halifax, Nova Scotia, Canada
Sexe:
ALLÂges:
18 - 100This is a study designed to see if a low dose of Lithium treatment, taken for 2 weeks, can improve fracture healing and improve patients' function and productivity.
Conditions:
FracturesEmplacement:
- Hamilton Health Sciences, Hamilton, Ontario, Canada
- Royal Victoria Regional Health Centre, Barrie, Ontario, Canada
- Unity Health St. Michael's Hospital, Toronto, Ontario, Canada
- The Ottawa Hospital Civic Campus, Ottawa, Ontario, Canada
- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Sexe:
ALLÂges:
18 - 55Mild traumatic brain injury (mTBI), also referred to as concussions, affect millions of people around the world and can cause harmful long term effects. Unfortunately, concussions can be hard to diagnose and many people have lasting post-concussion symptoms such as headaches, difficulty concentrating, and light sensitivity. Recent studies have shown that advanced magnetic resonance imaging (MRI) techniques can identify subtle brain changes caused by a concussion. This study aims to track concussions over time measuring MRI brain scans and post-concussion symptoms to gain a better understand how the brain is affected in comparison to symptoms.
Conditions:
Concussion, BrainEmplacement:
- Imaging Research Center at St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
Sexe:
ALLÂges:
9 - 50The REaCT NSQIP will compare oral antibiotics vs. no antibiotics, which are two standards of care treatments for preoperative preparation of the bowel prior to colorectal surgery
Conditions:
Elective Colon SurgeryEmplacement:
- The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
- The Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Queensway Carleton Hospital, Ottawa, Ontario, Canada
- Renfrew Victoria Hospital, Renfrew, Ontario, Canada
Sexe:
ALLÂges:
Over 18The goal of this trial is to compare self-reported resilience scores in junior physicians-in-training after completion of formal resilience training. The main questions this trial aims to answer are: * Does formal resilience training improve self-reported resilience scores? * Does the timing of resilience training (i.e., first vs second year of residency training) impact the effect of training? All participants will be provided with resources on resilience and learner support as per usual institutional practice. The intervention group will also participate in a formal resilience training program. Researchers will compare self-reported resilience scores 3 months after training to determine the effect of the training program.
Conditions:
Stress, EmotionalEmplacement:
- London Health Sciences Centre, London, Ontario, Canada
Sexe:
ALLÂges:
AnyThe purpose of this study is to understand how the brain responds to sounds and words, and how this response varies between individuals. The purpose if this study is to develop data set comparing the results from one individual with those from other members (a reference interval database of NeuroCatch® Platform 2) and to quantify the expected distribution across sex and age. NeuroCatch® Platform 2, is a medical device approved by Health Canada. The plan is to enroll 810 participants, the study includes screening for eligibility and one brain scan. The study is conducted at the Centre for Neurology Studies in Surrey, BC or at its satellite sites ( if required).
Conditions:
Brain Function | Healthy ControlsEmplacement:
- Centre for Neurology Studies, 13761 96 Ave, Unit 1004, Surrey, British Columbia, Canada